E5: (Pt2) Vidya Vasu-Devan - Gates Strategic Investment Fund. How does early stage biotech affect the majority world? What is the impact of volume guarantees?
03/15/19 • 20 min
In the second part of a two-part interview, Vidya dives into the Bill & Melinda Gates Strategic Investment Fund (SIF) strategy investing in early-stage biotech companies as well as volume guarantees.
Host: Hunter Sims
Producer: Allison Sims
Music: "Nowhere Land" Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0 License
In the second part of a two-part interview, Vidya dives into the Bill & Melinda Gates Strategic Investment Fund (SIF) strategy investing in early-stage biotech companies as well as volume guarantees.
Host: Hunter Sims
Producer: Allison Sims
Music: "Nowhere Land" Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0 License
Previous Episode
E4: (Pt1) Vidya Vasu-Devan - Gates Strategic Investment Fund. Why have a VC fund at the Gates Foundation? What can be learned from M-KOPA?
Next Episode
E6 How do you raise 100M in frontier markets? Gustaf Agartson & the BIMA founder's story
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/frontier-market-investing-127759/e5-pt2-vidya-vasu-devan-gates-strategic-investment-fund-how-does-early-6374281"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to e5: (pt2) vidya vasu-devan - gates strategic investment fund. how does early stage biotech affect the majority world? what is the impact of volume guarantees? on goodpods" style="width: 225px" /> </a>
Copy
